Home » Topics » BioWorld Science

BioWorld Science
RSS

Pfizer presents new sulfonamide-based compounds with high selectivity for MMP-3

Sep. 10, 2001

Modified second-generation taxoids: design and SAR discussed at ACS

Sep. 10, 2001

Endothelin receptor antagonists identified by Actelion team

Sep. 10, 2001

Liver-specific MRI contrast agent launched in Sweden

Sep. 10, 2001

Three related series of PDE4 inhibitors in development at Icos

Sep. 10, 2001

Modulators of dopamine neurotransmission presented in recent patents

Sep. 10, 2001

ADIR patents novel treatments for endothelial dysfunction

Sep. 10, 2001

New series of chemokine receptor-binding compounds and uses reported by AnorMED

Sep. 10, 2001

Org-30659 comparable to desogestrel for effects on ovarian function

Sep. 7, 2001

AltaRex completes primary analysis of OvaRex clinical trial

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.